Contributions
Abstract: EP1535
Type: ePoster
Abstract Category: Therapy - disease modifying - Tools for detecting therapeutic response
Introduction: Medicine connected takes an important place in daily life and medical practice and the care of patients, especially in the field of multiple sclerosis (MS).
Objectives: Our aim was to study the impact of the web-based personal record MSdialog® medical device on the exercise of inhealth professionals practice and measure its contribution to patient care, during in consultation or in therapeutic patient education session in France.
Patients and methods: This is an observational qualitative study. A survey was sent to a health care professionals group using MSdialog® in the monitoring of patients treated with interferon beta-1a subcutaneously with Rebismart2® injector. These health care professionals were asked to provide their opinion on the platform and its tools since its launch in France.
Results: Surveys concerning MSdialog® were sent to 10 neurologists (hospital and private practice-based), 12 nurses and 3 health managers, all specialized in therapeutic patient education. The surveys showed that MSdialog® has a positive effect (95%), with assistance in consultation (90%) and a better involvement of patients (91%), without increasing consultation time (62%). Adherence to treatment was recorded in 75% of users. The most used health surveys available on MSdialog® are those assessing the mood, fatigue and quality of life.
Discussion: The use of the MSdialog® platform allows better recording of treatment adhesion. It also provides a deeper evaluation of patients through the proposed health questionnaires as fatigue, pain and quality of life. This platform could eventually be opened to all MS patients and include other aspects such as cognitive activities, developing currently on Msdialog®.
Conclusion: MSdialog® is a new virtual medical approach. It allows health care professionals to perform support for MS patients in the follow-up, adhesion monitoring and in the evolution of chosen qualitative scales.
Disclosure: work done with the institutional support of the laboratory Merck Serono
Abstract: EP1535
Type: ePoster
Abstract Category: Therapy - disease modifying - Tools for detecting therapeutic response
Introduction: Medicine connected takes an important place in daily life and medical practice and the care of patients, especially in the field of multiple sclerosis (MS).
Objectives: Our aim was to study the impact of the web-based personal record MSdialog® medical device on the exercise of inhealth professionals practice and measure its contribution to patient care, during in consultation or in therapeutic patient education session in France.
Patients and methods: This is an observational qualitative study. A survey was sent to a health care professionals group using MSdialog® in the monitoring of patients treated with interferon beta-1a subcutaneously with Rebismart2® injector. These health care professionals were asked to provide their opinion on the platform and its tools since its launch in France.
Results: Surveys concerning MSdialog® were sent to 10 neurologists (hospital and private practice-based), 12 nurses and 3 health managers, all specialized in therapeutic patient education. The surveys showed that MSdialog® has a positive effect (95%), with assistance in consultation (90%) and a better involvement of patients (91%), without increasing consultation time (62%). Adherence to treatment was recorded in 75% of users. The most used health surveys available on MSdialog® are those assessing the mood, fatigue and quality of life.
Discussion: The use of the MSdialog® platform allows better recording of treatment adhesion. It also provides a deeper evaluation of patients through the proposed health questionnaires as fatigue, pain and quality of life. This platform could eventually be opened to all MS patients and include other aspects such as cognitive activities, developing currently on Msdialog®.
Conclusion: MSdialog® is a new virtual medical approach. It allows health care professionals to perform support for MS patients in the follow-up, adhesion monitoring and in the evolution of chosen qualitative scales.
Disclosure: work done with the institutional support of the laboratory Merck Serono